D-1005-2019 Class II Terminated

Recalled by Macleods Pharma Usa Inc — Plainsboro, NJ

FDA drug recall D-1005-2019 was initiated by Macleods Pharma Usa Inc on Feb 25, 2019 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications: The product is out of specification for blend uniformity. The recall status is terminated (terminated Jul 12, 2021). Affected quantity: 134495 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Feb 25, 2019
Termination Date
Jul 12, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
134495 bottles

Product description

Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-130-07

Reason for recall

Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.

Distribution pattern

Nationwide within the United States

Code information

Lot #: BTN703A, BTN704A Exp Feb-19; BTN705A, BTN706A, Exp May-19; BTN707A, Exp Jun-19; BTN810A, Exp Jun-20; BTN811A, BTN812A Exp Aug-20; BTN813A, BTN814A, Exp Sep-20; BTN802A, BTN802B, BTN803A, BTN804A, Exp Dec-19; BTN805A, BTN806A, BTN807A, BTN807B, Exp Feb-20; BTN808A, Exp Apr-20; BTN809A, BTN810A, Exp Jun-20; BTN811A, BTN812A, Exp Aug-20; BTN813A, BTN814A, Exp Sep-20.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1005-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1005-2019. Report a data issue: hello@regdatalab.com.